Winton Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-33,713
Closed -$294K 1522
2021
Q3
$294K Sell
33,713
-14,468
-30% -$132K 0.02% 1103
2021
Q2
$492K Sell
48,181
-11,136
-19% -$118K 0.03% 930
2021
Q1
$709K Buy
59,317
+9,760
+20% +$111K 0.04% 670
2020
Q4
$450K Sell
49,557
-8,155
-14% -$63.1K 0.03% 842
2020
Q3
$351K Buy
+57,712
New +$440K 0.01% 1203
2019
Q4
Sell
-68,351
Closed -$416K 1836
2019
Q3
$416K Buy
+68,351
New +$384K ﹤0.01% 1149

Other funds holding NPTN

Winton Group's NPTN Position: Q4 2021 in Review

Winton Group sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 33,713 shares — an estimated $294K sold.

Winton Group first reported a position in NPTN in Q3 2019 and held it in 6 quarters. The position peaked at $709K in Q1 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • Winton Group reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 33,713 NEOPHOTONICS CORP shares in Q4 2021, an estimated $294K.
  • Winton Group first reported a position in NEOPHOTONICS CORP in Q3 2019 and held it in 6 quarters.
  • Winton Group's NEOPHOTONICS CORP position peaked at $709K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.